According to Xinhua Medical's announcement, the first half of 2026 achieved operating income of 5.161 billion yuan, an increase of 7.73%; net profit attributable to shareholders of listed companies was 285 million yuan, a year-on-year decrease of 26.04%; and net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 263 million yuan, a year-on-year decrease of 20.92%. Basic earnings per share were $0.47, down 26.56% year over year. There were no profit distribution plans or plans to increase share capital from the Provident Fund during the reporting period.

According to Xinhua Medical's announcement, the first half of 2026 achieved operating income of 5.161 billion yuan, an increase of 7.73%; net profit attributable to shareholders of listed companies was 285 million yuan, a year-on-year decrease of 26.04%; and net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 263 million yuan, a year-on-year decrease of 20.92%. Basic earnings per share were $0.47, down 26.56% year over year. There were no profit distribution plans or plans to increase share capital from the Provident Fund during the reporting period.